Bank of New York Mellon
IDIX

Bank of New York Mellon’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Bank of New York Mellon’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-548,058
Closed -$13.2M – 4284
2014
Q2 		$13.2M Buy
548,058
+7,462
+1% +$77.8K ﹤0.01% 1744
2014
Q1 		$3.26M Buy
540,596
+46,790
+9% +$326K ﹤0.01% 2566
2013
Q4 		$2.95M Buy
493,806
+2,668
+0.5% +$12.3K ﹤0.01% 2634
2013
Q3 		$2.55M Buy
491,138
+38,533
+9% +$169K ﹤0.01% 2692
2013
Q2 		$1.63M Buy
+452,605
New +$1.85M ﹤0.01% 2908

Bank of New York Mellon's IDIX Position: Q3 2014 in Review

Bank of New York Mellon sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 548,058 shares — an estimated $13.2M sold.

Bank of New York Mellon first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $13.2M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Bank of New York Mellon reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Bank of New York Mellon sold 548,058 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $13.2M.
  • Bank of New York Mellon first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Bank of New York Mellon's IDENIX PHARMACEUTICALS INC position peaked at $13.2M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Bank of New York Mellon's 13F filing for Q3 2014, filed 13 Nov 2014.